Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemosiderin is an insoluble, intracellular protein complex that serves as a primary form of iron storage in the body, particularly when iron levels exceed the storage capacity of ferritin (StatPearls). It consists of aggregates of ferritin, denatured ferritin, and other materials like lipids and carbohydrates, primarily found within macrophages of the liver, spleen, and bone marrow (NIH). While it plays a physiological role in sequestering potentially toxic free iron, pathological accumulation leads to visible hemosiderin staining in the skin—common in chronic venous insufficiency—or organ damage in systemic iron overload conditions like hemochromatosis (Mayo Clinic). Therapeutic targeting of hemosiderin involves the use of iron chelators, such as Deferoxamine, which mobilize iron for excretion, or dermatological interventions like Q-switched lasers that mechanically disrupt the pigment for biological clearance. The provided term 'Hemosiderin pigment removal' refers to a clinical procedure or outcome rather than a specific molecular target, which is properly identified as the hemosiderin complex itself.
Iron chelators bind to the ferric iron (Fe3+) within the hemosiderin complex, forming stable, soluble complexes that can be excreted by the kidneys or liver (PubChem). In aesthetic applications, lasers utilize selective photothermolysis to fragment pigment particles, facilitating clearance by macrophages (StatPearls).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemosiderin.